Board of Directors (SS Innovations International, Inc.)

Dr. Sudhir Srivastava
Dr. Srivastava, along with ten additional physicians, founded Alliance Hospital LTD, a center of excellence in the treatment of cardiovascular disease, in Odessa, Texas in July 2003 and served as its chairman for four years. While there, he performed the world’s first single vessel beating heart TECAB in the United States. He also proceeded to perform two world’s first double and triple vessel TECAB on a beating heart and is the only person in the world to have performed a quadruple vessel beating heart TECAB while at the University of Chicago.
Dr. Srivastava is an active member of the Society of Thoracic Surgeons, AATS, the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and is a founder of the Robotic Revascularization Society.
Dr. Srivastava has made it his mission to make available his skill to all those with the desire to learn these minimally invasive techniques. Dr. Srivastava has trained hundreds of teams around the world and is constantly trying to find ways to improve the field of robotic assisted surgery.
Alongside his tireless efforts and determination, Dr. Srivastava continues to push the envelope of surgical science as we know it today

Frederic Moll, MD - Vice Chairman
Dr. Moll’s career began in surgical residency at Virginia Mason Medical Center, where he saw the potential to minimize surgical invasiveness. This realization led him to develop the safety trocar, enabling safer laparoscopic procedures. Following this innovation, he launched and led several successful medical device companies. Among his earliest ventures were Endotherapeutics and Origin Medsystems, both acquired by major corporations and instrumental in advancing laparoscopic surgery.
In 1995, Dr. Moll co-founded Intuitive Surgical, where he co-developed the groundbreaking da Vinci robotic-assisted surgery system, which remains a global standard for minimally invasive surgery. He continued his pioneering work by founding Hansen Medical, focusing on robotic technology for vascular and electrophysiology procedures, and later, Auris Health, where he developed the Monarch platform for robotic endoscopy. This innovative technology, acquired by Johnson & Johnson in 2019, advanced the diagnosis and treatment of lung cancer.
Dr. Moll has served on the boards of several influential healthcare technology companies, including Mako Surgical and RefleXion, where he has championed innovations in robotic surgery and cancer treatment. With decades of experience and a commitment to revolutionizing healthcare, Dr. Moll’s contributions have left a lasting impact on medical technology and patient care worldwide.

Vishwa Srivastava, MD - CEO APAC
In 2009, while working as the Director of Digital Media and Technology at St. Joseph’s Hospital in Atlanta, Vishwa was the first person in the field to develop a high definition teaching website for robotic cardiac surgery. The goal was to assist in cardiothoracic surgeons lessening their respective learning curves through didactic training modules as they transitioned from conventional approaches to minimally invasive robotic approaches.
Soon after, he began his research in the concept of tele-mentoring in surgical procedures. In 2011, while working as the VP of Marketing and Technology at the International Centre for Robotic Surgery in New Delhi, Vishwa led the development of the OMNI 3D Medical Visualization system. The 2013-2014 clinical trials for the OMNI system were conducted at Shanghai Ruijin Hospital, Medanta Hospital in New Delhi, the University of Chicago, Temple University in Philadelphia and Lennox Hill Hospital in New York City.
Vishwa presently serves as the Chief Executive Officer – Asia Pacific of SS Innovations and is advancing the existing technological platform for availability in the global surgical endoscopic marketplace.

Barry Cohen - COO - Americas
Barry Cohen is currently the Chief Operating Office of the Americas for Sudhir Srivastava Innovations Pvt. ltd. After the merger between SSInnovations and Avra Medical Robotics Inc. He also serves as the Chairman of the Board at Avra Medical Robotics Inc. Mr. Cohen founded the company and has served as its Chief Executive Officer and director since February 4, 2015. Between 2006 and 2008, Mr. Cohen was a private investor and founded Avra Surgical, Inc. a medical technology company. From approximately 1979 to 1989, he served as director of Synalloy Corp., a manufacturer of pipe, piping systems and specialty chemicals after which he was appointed to serve as President from 1984 to 1985. Mr. Cohen also served as Chairman of the executive Board of Wolverine Technologies, Inc., a NYSE listed company from 1979 to 1983 and President Barry F. Cohen & Co., an NASD member from 1983 to 1999. Mr. Cohen has over 50 years of experience in managing private and public industrial companies, and 47 years experience as a securities manager.

Dr. Mylswamy Annadurai

Somashekhar SP, MD - Aster DM Healthcare - GCC & India
Dr. Somashekhar, who is one among the most accomplished super speciality consultants in Surgical Oncology, Robotic Surgery, HIPEC, PIPAC in India, as the Chairman of Medical Advisory Boarding & Global Director of Aster International Institute of Oncology.
- Dr Somashekhar who did his MBBS from Mysore University, MS (Gen. Surgery) from NHL Medical College, MCh (Surgical Oncology) from GCRI Regional Cancer Centre has various other academic accomplishments including Fellowship in Robotic Surgery from Roswell Cancer Centre, Buffalo, USA. He had training in Gynaecological Oncology at Mayo Clinic, Rochester, Advanced Liver Surgery at Paul Brouses Hospital, Paris, Thoracic Onco Fellowship at Shanghai Chest Institute Beijing, Breast & Oncoplasty Fellowship from IEO Italy and UPMC Pittsburgh. He has performed over 3000 Robotic Surgeries which is the highest number of complex Robotic Onco Surgeries in the country and over 1000 HIPEC procedure in abdominal cancers, which is the largest series in Asia. He was instrumental in introducing SLNB Sentinel Node Biopsy in India way back in 2001.
- Prof. Dr. Somashekhar has been awarded the prestigious Dr. D. D. Patel Gold Medal for his excellency in Onco Surgery and a Fellow from the Royal College of Surgeons, Edinburgh. He has authored several textbooks on Oncology and has over 300 publications in International and National Journals. He has been honoured with the prestigious Dronacharya Teachers Award for his contribution in the field of Surgical Oncology. He has also been awarded the Times Award for Excellence in Oncology, the Deccan Herald Excellency Award in Oncology, and the prestigious ASI P K Sinha Oration Award. He has been invited for the most prestigious orations in Royal College of Surgeons and Gynaecological Oncology, UK, Canada, Australia and US. He is conferred the most prestigious Bulkley-Barry-Cooper Professorship: Kings Health Partner, UK, London. He is also ex-Adjunct Professor Surgical Oncology, KMC University. He has trained over 134 surgical students in various sub-specialities. He is also Teacher and University Examiner in the field of Surgical Oncology for both MCh and DrNB Surgical Oncology (NBE board). He is Intuitive International Mentor and Trainer in the field of Robotic Surgery.
- Before joining Aster, Prof. Dr. Somashekhar S P worked with Manipal Group of Hospitals as Chairman, Oncology, MHEPL and Manipal Comprehensive Cancer Center, HOD Department of Surgical & Gynec. Oncology, Bangalore and as Member Board of Studies, Manipal University, Manipal and Director of Breast Surgery & Oncoplasty, Robotic Surgery and Gynaecological Oncology University Fellowship Programs. He is the Ex-President of ABSI Association of Breast Surgeons of India, and Editor in Chief at Springer Indian Journal of Gynec Onco, Editor of Annals of Breast Diseases Journal, EC Council Member of PSOGI (Peritoneal Surface Oncology Group International) and Council Member of ISSPP (International Society Study of Peritoneum and Pleural), Council Member of AGOI (Association of Gynaec Oncology India), Hon. Secretary of ISPSM (Indian Society of Peritoneal Surface Malignancy) and Founding Member of CRSA-I (Clinical Robotic Surgeons Association India), Office Bearer of Indian Association of Surgical Oncologist and Association of Gynec. Oncologists of India.

Tim Adams
With a proven track record in healthcare leadership, Tim joined Ascension after holding the role of Texas Region Chief Executive Officer at Tenet Healthcare, where he managed 26 hospitals and led operational efforts for one of the company’s largest regions. He was also instrumental in Tenet’s hospital integration and operations, overseeing acquisitions, enterprise-wide initiatives, and post-acute service lines.
Previously, Tim served as CEO of Cedar Park Regional Medical Center, a partner with Ascension’s Seton Healthcare Family, and held executive roles at Community Health Systems and IASIS Healthcare, overseeing multi-hospital operations in Texas and Florida.
Beyond his professional role, Tim is a dedicated member of the healthcare community, actively serving on numerous boards, including the Tennessee Hospital Association, Nashville Health Care Council, and the United Way of Greater Nashville. He holds a Bachelor of Business Administration from Baylor University and an MBA from The University of Texas at El Paso.
Tim’s leadership is distinguished by his commitment to fostering innovation, community partnerships, and comprehensive care across the region.
Board of Directors (Sudhir Srivastava Innovations Pvt. Ltd.)



Sudhir K Rawal, MD - Rajiv Gandhi Cancer Institute
Dr. Sudhir Rawal is one of the leading Uro-Oncology surgeons in India, with special interest in Robotic Surgery. He has more than 30 years of experience in Genito Urinary Oncosurgery.
He routinely performs procedures such as Radical Prostatectomy, Radical Cystectomy, Radical Hysterectomy, RPLND, and complex urinary diversion like continent pouch and neo bladder.
“Pitcher’s pot Ileal Neobladder” is one of his innovations which finds place in leading urology publications.
He is the first URO-GYN surgical oncologist of North India and heading the department since the inception of the Rajiv Gandhi Cancer Institute. He did first open Retropubic Radical Prostatectomy in private sector in India. Besides this he has done the highest volume of Radical Prostatectomy, Radical Cystoprostatectomy Neobladder, Robotic VEIL, Robotic RPLND (Post Chemo) in India.

Executive Team


Mr. Avinash Kumar - COO
Avinash Kumar is the Chief Operating Officer for SS Innovations, a seasoned executive with a background in science and engineering and over 25 years of experience. His expertise lies in managing manufacturing operations, vertical integrations, and medical product assemblies.
Throughout his career, Mr. Kumar has demonstrated the ability to lead large teams of over 500 people and has hands-on experience establishing manufacturing facilities in Asia, Africa, and the US. His leadership roles have included managing P&L responsibility with operating budgets of $35 million and heading factory operations with budgets of nearly $10 million. He was a key member of an expansion team that managed a project of over $250 million to increase production capacity for a range of medical products, including syringes, needles, and IV sets.
Mr. Kumar’s extensive international exposure includes serving as the General Director of Asia Operations for Nextern Inc. in China and Vietnam and as a General Manager in Nigeria for Pan African Health Foundation/IMI. He has successfully implemented critical quality management systems, including ISO 13485:2016, GMP, CE, FDA, and WHO-PQS, in addition to methodologies like Six Sigma and Lean manufacturing. His accomplishments also include significantly increasing manufacturing efficiency (OEE) from 78% to 96% in a previous role.
His technical expertise is built on a strong educational foundation, including a Bachelor’s degree in Mechanical Engineering and a 4-year engineering degree in Tool & Die Making.


Srinivasa Reddy
Experience
•Sr. VP – Operations, Regulatory and Govt. Affairs – Sudhir Srivastava Innovations Pvt. Ltd., India — 2023 – present
•Director (Operations and Regulatory Affairs) – Sudhir Srivastava Innovations Pvt. Ltd., India — 2020 – 2023
•Assistant Director (Technical and Business Development) – AMTZ and KIHT — 2017 – 2020
•Head (Biomedical Department) – Continental Hospitals Pvt. Ltd., Parkway Pantai Group of Hospitals, Hyderabad – 2013 – 2017
•Electro Medical Engineer (Department of Medical Physics) – Ninewells Hospital, UK – 2010 – 2013
•Sales and Service Engineer – Advanced Micronic Devices Ltd. – 2006 – 2008
Education
•Andhra University – MBA Hospital Administration
•University of Dundee, UK – Masters Biomedical Engineering
•Tenet Health Edutech Pvt. Ltd. – PG Diploma in Clinical Research for Medical Devices
•JNTU, Hyderabad – Bachelors in Biomedical Engineering
•SGPR Polytechnic College – Diploma in Biomedical Engineering
Memberships
•AMIE- Associate Member of Institution of Engineers
•MISC-Life Member of Indian Science Congress
•APCBEES-Asia- Life member of Pacific Chemical, Biological& Environmental Engineering Society
•IACS – Life Member of International Association of Computer Science IT
•ISO 13485 – Lead Auditor


Sonia Shokeen, Head of Quality & Regulatory
Dr. Shokeen holds a doctorate degree in biomedical science from University of South Dakota, USA. She has over 15 years of experience in medical device industry working with Class II and Class III devices for Restorative, Stroke, and minimally invasive (including robotics) therapies.
Prior to joining SSI, she held senior quality leadership positions at Medtronic and Johnson & Johnson in the US.”


Vaishali Singh - Company Secretary
Vaishali Singh, an accomplished professional delivering 8 years of career success in Corporate & Compliance management.
Vaishali’s dexterity lies in performing Secretarial & FEMA functions of the Company.
Before joining SS Innovations, she had worked with Clove Dental group (India’s largest Dental Chain) as a Company Secretary for over four years handling Secretarial & FEMA Compliances.
